PULMATRIX, INC. Interest Income, Other
PULMATRIX, INC. (PULM) reported Interest Income, Other of $103.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2019-08-05
- PULMATRIX, INC. interest income, other for the quarter ending 2019-06-30 was $103.00K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month |
|---|---|---|
| 2019-06-30 | $103.00K 10-Q · filed 2019-08-05 | $106.00K 10-Q · filed 2019-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |